Perrigo Company signed an agreement with Kairos Bidco AB to sell its Dermacosmetics-branded business for up to €327 million ($374 million).WHO: Perrigo Company is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market. Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private-label offerings fuel investments for leading brands, including Opill, Mederma, Compeed, EllaOne, and Jungle Formula.KKR is a leading global investment firm with approximately $664 billion in assets under management. KKR invests globally across private equity, credit, and real assets like infrastructure and real estate, and also offers capital markets and insurance solutions. KKR follows a patient and disciplined investment approach with deep expertise across consumer health and beauty products, with recent investments including category leaders such as Karo Healthcare (subject to closing), The Bountiful Company, Wella Company, Coty, Vini Cosmetics, KDC/ONE, and Arnott's Group. WHY: This transaction advances Perrigo's Three-S plan to Stabilize, Streamline, and Strengthen the organization, honing its strategic focus to invest in its "high-grow," high-return opportunities.IN THEIR OWN WORDS: "This transaction marks another significant milestone in the execution of our 'Three-S' plan," said Patrick Lockwood-Taylor, Perrigo President and Chief Executive Officer.